DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,162,838 | +90244.4% | 72,063 | -4.9% | 0.50% | -13.1% |
| Q4 2022 | $20,104 | -99.9% | 75,743 | -2.4% | 0.57% | -7.9% |
| Q3 2022 | $20,049,000 | +0.8% | 77,621 | -1.1% | 0.62% | +10.7% |
| Q2 2022 | $19,891,000 | -13.5% | 78,461 | +0.0% | 0.56% | +0.9% |
| Q1 2022 | $23,005,000 | +2.1% | 78,426 | +14.6% | 0.56% | +0.2% |
| Q4 2021 | $22,522,000 | -10.0% | 68,454 | -16.7% | 0.56% | -4.3% |
| Q3 2021 | $25,016,000 | +18.2% | 82,171 | +4.2% | 0.58% | +23.7% |
| Q2 2021 | $21,159,000 | +16.6% | 78,846 | -2.2% | 0.47% | +12.7% |
| Q1 2021 | $18,149,000 | +2.7% | 80,634 | +1.4% | 0.42% | +15.6% |
| Q4 2020 | $17,668,000 | +8.7% | 79,534 | +5.3% | 0.36% | -0.3% |
| Q3 2020 | $16,259,000 | +21.2% | 75,507 | -0.5% | 0.36% | +16.8% |
| Q2 2020 | $13,419,000 | +19.4% | 75,889 | -6.5% | 0.31% | +7.7% |
| Q1 2020 | $11,236,000 | -14.6% | 81,181 | -5.3% | 0.29% | +6.7% |
| Q4 2019 | $13,158,000 | +0.9% | 85,731 | -5.0% | 0.27% | -6.6% |
| Q3 2019 | $13,038,000 | -7.7% | 90,269 | -8.6% | 0.29% | -8.0% |
| Q2 2019 | $14,123,000 | -0.6% | 98,815 | -8.2% | 0.31% | -3.1% |
| Q1 2019 | $14,213,000 | +21.0% | 107,656 | -5.5% | 0.32% | +6.6% |
| Q4 2018 | $11,750,000 | -1.7% | 113,946 | +3.6% | 0.30% | -9.8% |
| Q3 2018 | $11,950,000 | +10.7% | 109,980 | +0.5% | 0.34% | +5.0% |
| Q2 2018 | $10,795,000 | +0.9% | 109,394 | +0.1% | 0.32% | -3.3% |
| Q1 2018 | $10,695,000 | +6.1% | 109,233 | +0.6% | 0.33% | +4.7% |
| Q4 2017 | $10,081,000 | +8.3% | 108,612 | +0.1% | 0.32% | +6.8% |
| Q3 2017 | $9,305,000 | +0.5% | 108,470 | -1.1% | 0.30% | -3.9% |
| Q2 2017 | $9,258,000 | -2.4% | 109,701 | -1.1% | 0.31% | -5.2% |
| Q1 2017 | $9,485,000 | +8.5% | 110,898 | -1.2% | 0.32% | +3.2% |
| Q4 2016 | $8,742,000 | -3.0% | 112,301 | -2.4% | 0.32% | -7.1% |
| Q3 2016 | $9,015,000 | -23.9% | 115,004 | -2.0% | 0.34% | -26.0% |
| Q2 2016 | $11,854,000 | +2261.4% | 117,362 | +1900.7% | 0.46% | +1981.8% |
| Q2 2015 | $502,000 | -30.1% | 5,866 | -30.6% | 0.02% | -29.0% |
| Q1 2015 | $718,000 | -0.1% | 8,454 | +0.7% | 0.03% | -6.1% |
| Q4 2014 | $719,000 | +5.1% | 8,394 | -6.8% | 0.03% | -5.7% |
| Q3 2014 | $684,000 | -4.5% | 9,004 | -1.0% | 0.04% | -2.8% |
| Q2 2014 | $716,000 | +23.2% | 9,098 | +17.4% | 0.04% | +12.5% |
| Q1 2014 | $581,000 | -2.8% | 7,750 | 0.0% | 0.03% | -3.0% |
| Q4 2013 | $598,000 | +11.4% | 7,750 | 0.0% | 0.03% | -5.7% |
| Q3 2013 | $537,000 | +9.1% | 7,750 | -0.3% | 0.04% | +20.7% |
| Q2 2013 | $492,000 | – | 7,770 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |